Responses
Regular and Young Investigator Award Abstracts
Immune-Stimulants and Immune Modulators
1060 EVOLVETM: a novel costimulatory T cell engager platform engineered for the treatment of immune suppressive tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.